# Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome

> **NCT05944562** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 24 (actual)

## Conditions studied

- Mycosis Fungoides
- Sezary Syndrome
- Mycosis Fungoides/Sezary Syndrome

## Interventions

- **DRUG:** Tulmimetostat

## Key facts

- **NCT ID:** NCT05944562
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-09
- **Primary completion:** 2027-02-28
- **Final completion:** 2029-01-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944562, "Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT05944562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*